Innate Pharma SA announces the outcome of its AGM that took place on June 27, 2008, in Marseilles and updates on the divestment process by Novo Nordisk A/S of its rights to IPH 2101.
PR in english | 84.7 KB |
CP en français | 83.15 KB |
Innate Pharma SA announces the outcome of its AGM that took place on June 27, 2008, in Marseilles and updates on the divestment process by Novo Nordisk A/S of its rights to IPH 2101.
PR in english | 84.7 KB |
CP en français | 83.15 KB |